Biomimetic proteolipid vesicles for targeting inflamed tissues
暂无分享,去创建一个
A. De Vita | I. K. Yazdi | M. Sherman | E. Tasciotti | E. De Rosa | Jonathan O. Martinez | M. Evangelopoulos | A. Parodi | F. Taraballi | R. Molinaro | C. Corbo | J. Martinez | S. Minardi | P. Zhao | N. T. Toledano Furman | X. Wang | N. T. Furman | Iman K. Yazdi | E. Rosa | Picheng Zhao | Michael B. Sherman | A. D. Vita | Xin Wang
[1] Liangfang Zhang,et al. Cell membrane-camouflaged nanoparticles for drug delivery. , 2015, Journal of controlled release : official journal of the Controlled Release Society.
[2] Anna Tampieri,et al. Evaluation of the osteoinductive potential of a bio-inspired scaffold mimicking the osteogenic niche for bone augmentation. , 2015, Biomaterials.
[3] Mauro Ferrari,et al. Principles of nanoparticle design for overcoming biological barriers to drug delivery , 2015, Nature Biotechnology.
[4] M. Ueda,et al. Integrin LFA-1 regulates cell adhesion via transient clutch formation. , 2015, Biochemical and biophysical research communications.
[5] Ronnie H. Fang,et al. Nanoparticle biointerfacing via platelet membrane cloaking , 2015, Nature.
[6] E. Tasciotti,et al. Biodegradable silicon nanoneedles delivering nucleic acids intracellularly induce localized in vivo neovascularization. , 2015, Nature materials.
[7] E. Tasciotti,et al. Proteomic Profiling of a Biomimetic Drug Delivery Platform. , 2014, Current drug targets.
[8] Samir Mitragotri,et al. Platelet-like Nanoparticles: Mimicking Shape, Flexibility, and Surface Biology of Platelets To Target Vascular Injuries , 2014, ACS nano.
[9] V. Torchilin. Multifunctional, stimuli-sensitive nanoparticulate systems for drug delivery , 2014, Nature Reviews Drug Discovery.
[10] S. Doglia,et al. A Fourier transform infrared spectroscopy study of cell membrane domain modifications induced by docosahexaenoic acid. , 2014, Biochimica et biophysica acta.
[11] Ronnie H. Fang,et al. Clearance of pathological antibodies using biomimetic nanoparticles , 2014, Proceedings of the National Academy of Sciences.
[12] Brandon S. Brown,et al. Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular Matrix , 2014, ACS nano.
[13] Samir Mitragotri,et al. Overcoming the challenges in administering biopharmaceuticals: formulation and delivery strategies , 2014, Nature Reviews Drug Discovery.
[14] Rachel A. Kudgus,et al. Tuning Pharmacokinetics and Biodistribution of a Targeted Drug Delivery System Through Incorporation of a Passive Targeting Component , 2014, Scientific Reports.
[15] Carmen Alvarez-Lorenzo,et al. Bioinspired drug delivery systems. , 2013, Current opinion in biotechnology.
[16] Patrick Couvreur,et al. Stimuli-responsive nanocarriers for drug delivery. , 2013, Nature materials.
[17] Marcelle Machluf,et al. Reconstructed stem cell nanoghosts: a natural tumor targeting platform. , 2013, Nano letters.
[18] Ronnie H. Fang,et al. 'Marker-of-self' functionalization of nanoscale particles through a top-down cellular membrane coating approach. , 2013, Nanoscale.
[19] E. Azzopardi,et al. The enhanced permeability retention effect: a new paradigm for drug targeting in infection. , 2013, The Journal of antimicrobial chemotherapy.
[20] Hatem Fessi,et al. Preparation, Characterization and Applications of Liposomes: State of the Art , 2012 .
[21] C. Veigel,et al. Effect of Envelope Proteins on the Mechanical Properties of Influenza Virus* , 2012, The Journal of Biological Chemistry.
[22] Jeffrey W. Smith,et al. Platelet Mimetic Particles for Targeting Thrombi in Flowing Blood , 2012, Advanced materials.
[23] D. Paolino,et al. Gemcitabine and tamoxifen-loaded liposomes as multidrug carriers for the treatment of breast cancer diseases. , 2012, International journal of pharmaceutics.
[24] K. Ley,et al. Leukocyte ligands for endothelial selectins: specialized glycoconjugates that mediate rolling and signaling under flow. , 2011, Blood.
[25] Ildar Khalidov,et al. Inflamed leukocyte-mimetic nanoparticles for molecular imaging of inflammation. , 2011, Biomaterials.
[26] D. Irvine,et al. Bio-inspired, bioengineered and biomimetic drug delivery carriers , 2011, Nature Reviews Drug Discovery.
[27] Ronnie H. Fang,et al. Erythrocyte membrane-camouflaged polymeric nanoparticles as a biomimetic delivery platform , 2011, Proceedings of the National Academy of Sciences.
[28] G. Biggio,et al. Ex vivo skin delivery of diclofenac by transcutol containing liposomes and suggested mechanism of vesicle-skin interaction. , 2011, European journal of pharmaceutics and biopharmaceutics : official journal of Arbeitsgemeinschaft fur Pharmazeutische Verfahrenstechnik e.V.
[29] Min Zhang,et al. Membrane proteomic analysis of pancreatic cancer cells , 2010, Journal of Biomedical Science.
[30] Gregory P. Robbins,et al. Tunable leuko-polymersomes that adhere specifically to inflammatory markers. , 2010, Langmuir : the ACS journal of surfaces and colloids.
[31] S. Mura,et al. Penetration enhancer-containing vesicles (PEVs) as carriers for cutaneous delivery of minoxidil. , 2009, International journal of pharmaceutics.
[32] H. Ditzel,et al. Efficient isolation and quantitative proteomic analysis of cancer cell plasma membrane proteins for identification of metastasis-associated cell surface markers. , 2009, Journal of proteome research.
[33] David Piwnica-Worms,et al. Bioluminescence imaging of myeloperoxidase activity in vivo , 2009, Nature Medicine.
[34] M. Gorenstein,et al. The detection, correlation, and comparison of peptide precursor and product ions from data independent LC‐MS with data dependant LC‐MS/MS , 2009, Proteomics.
[35] Mauro Ferrari,et al. Mesoporous silicon particles as a multistage delivery system for imaging and therapeutic applications. , 2008, Nature nanotechnology.
[36] T S Chow,et al. Nanoscale surface roughness and particle adhesion on structured substrates , 2007 .
[37] F. Tama,et al. Removal of Divalent Cations Induces Structural Transitions in Red Clover Necrotic Mosaic Virus, Revealing a Potential Mechanism for RNA Release , 2006, Journal of Virology.
[38] Ratnesh Lal,et al. Cisplatin nanoliposomes for cancer therapy: AFM and fluorescence imaging of cisplatin encapsulation, stability, cellular uptake, and toxicity. , 2006, Langmuir : the ACS journal of surfaces and colloids.
[39] M. Gorenstein,et al. Quantitative proteomic analysis by accurate mass retention time pairs. , 2005, Analytical chemistry.
[40] Eberhard Durr,et al. Direct proteomic mapping of the lung microvascular endothelial cell surface in vivo and in cell culture , 2004, Nature Biotechnology.
[41] J. M. Lanao,et al. Drug, enzyme and peptide delivery using erythrocytes as carriers. , 2004, Journal of controlled release : official journal of the Controlled Release Society.
[42] S. Marullo,et al. Nuclear Functions for Plasma Membrane‐Associated Proteins? , 2003, Traffic.
[43] D. Franchimont,et al. Glucocorticoids and Inflammation Revisited: The State of the Art , 2003, Neuroimmunomodulation.
[44] A. Sigal,et al. The LFA-1 Integrin Supports Rolling Adhesions on ICAM-1 Under Physiological Shear Flow in a Permissive Cellular Environment1 , 2000, The Journal of Immunology.
[45] R. Winter,et al. Interaction of the anticancer agent Taxol (paclitaxel) with phospholipid bilayers. , 1999, Journal of biomedical materials research.
[46] T. Allen. Liposomal Drug Formulations , 1998, Drugs.
[47] F. Sánchez‐Madrid,et al. Induction of tyrosine phosphorylation during ICAM-3 and LFA-1-mediated intercellular adhesion, and its regulation by the CD45 tyrosine phosphatase , 1994, The Journal of cell biology.
[48] T. Harrer,et al. CD45 mAb induces cell adhesion in peripheral blood mononuclear cells via lymphocyte function-associated antigen-1 (LFA-1) and intercellular cell adhesion molecule 1 (ICAM-1). , 1993, Cellular immunology.
[49] M. Bretscher. Asymmetrical lipid bilayer structure for biological membranes. , 1972, Nature: New biology.
[50] Anne L. van de Ven,et al. Synthetic nanoparticles functionalized with biomimetic leukocyte membranes possess cell-like functions. , 2013, Nature nanotechnology.
[51] D. Roberts,et al. Leukocyte Surface Antigen CD47 , 2013 .
[52] J. M. Lanao,et al. Cell-based drug-delivery platforms. , 2012, Therapeutic delivery.
[53] C. Demetzos. Differential Scanning Calorimetry (DSC): a tool to study the thermal behavior of lipid bilayers and liposomal stability. , 2008, Journal of liposome research.
[54] Markus Voelter,et al. State of the Art , 1997, Pediatric Research.
[55] G. Yarrington. Molecular Cell Biology , 1987, The Yale Journal of Biology and Medicine.